GH Research Past Earnings Performance
Past criteria checks 0/6
GH Research's earnings have been declining at an average annual rate of -55.2%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually.
Key information
-55.2%
Earnings growth rate
-52.1%
EPS growth rate
Pharmaceuticals Industry Growth | 6.0% |
Revenue growth rate | n/a |
Return on equity | -21.9% |
Net Margin | n/a |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
No updates
Recent updates
We're Hopeful That GH Research (NASDAQ:GHRS) Will Use Its Cash Wisely
Oct 11We're Hopeful That GH Research (NASDAQ:GHRS) Will Use Its Cash Wisely
Jun 21GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans
Mar 01GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans
Nov 17GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans
Jul 30We're Hopeful That GH Research (NASDAQ:GHRS) Will Use Its Cash Wisely
Mar 13Companies Like GH Research (NASDAQ:GHRS) Are In A Position To Invest In Growth
Nov 28GH Research GAAP EPS of $0.006
Aug 23We Think GH Research (NASDAQ:GHRS) Can Afford To Drive Business Growth
Aug 15GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans
Apr 29We're Not Very Worried About GH Research's (NASDAQ:GHRS) Cash Burn Rate
Jan 13GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans
Sep 30GH Research: A Recent IPO Stock That Could Possibly Be A Trailblazer In A Hot Industry
Aug 15Revenue & Expenses Breakdown
How GH Research makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 0 | -41 | 13 | 35 |
30 Jun 24 | 0 | -35 | 12 | 34 |
31 Mar 24 | 0 | -32 | 11 | 31 |
31 Dec 23 | 0 | -36 | 11 | 30 |
30 Sep 23 | 0 | -41 | 11 | 28 |
30 Jun 23 | 0 | -36 | 10 | 26 |
31 Mar 23 | 0 | -28 | 10 | 23 |
31 Dec 22 | 0 | -22 | 10 | 20 |
30 Sep 22 | 0 | -10 | 11 | 17 |
30 Jun 22 | 0 | -11 | 11 | 15 |
31 Mar 22 | 0 | -14 | 9 | 13 |
31 Dec 21 | 0 | -9 | 7 | 9 |
30 Sep 21 | 0 | -5 | 3 | 5 |
30 Jun 21 | 0 | -4 | 1 | 3 |
31 Mar 21 | 0 | -2 | 1 | 1 |
31 Dec 20 | 0 | 0 | 0 | 0 |
Quality Earnings: GHRS is currently unprofitable.
Growing Profit Margin: GHRS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GHRS is unprofitable, and losses have increased over the past 5 years at a rate of 55.2% per year.
Accelerating Growth: Unable to compare GHRS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GHRS is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (54.6%).
Return on Equity
High ROE: GHRS has a negative Return on Equity (-21.88%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 14:12 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
GH Research PLC is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Sumant Satchidanand Kulkarni | Canaccord Genuity |
Patrick Trucchio | H.C. Wainwright & Co. |
Jason Butler | JMP Securities |